Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
Confirm the efficacy of the brexpiprazole QW formulation versus placebo for acute symptoms of schizophrenia
Patients at least 18 years of age and below the age of 65 at the time of informe... [+6]
Patients presenting a first episode of schizophrenia based on the clinical judgm... [+17]